References

  1. Wynder EL, Muscat JE. The changing epidemiology of smoking and lung cancer histology. Environ Health Perspect. 1995;103(8):143-148. PubMed | Google Scholar

  2. Franceschi S, Bidoli E. The epidemiology of lung cancer. Ann Oncol. 1999;10 Suppl 5:S3-6. PubMed | Google Scholar

  3. Mlika M, Ayadi-Kaddour A, Boudaya S, Laabidi S, Boussen H, El Mezni F. La nouvelle classification des adénocarcinomes pulmonaires proposée par la société thoracique américaine et la société respiratoire européenne: de nouvelles recommandations pour une meilleure prise en charge. Tunis Med. 2013;91(5):293-299. PubMed | Google Scholar

  4. Qian C, Liu XY, Prieto J. Therapy of cancer by cytokines mediated by gene therapy approach. Cell Res. 2006; 16(2):182-8. PubMed | Google Scholar

  5. Travis WD, Travis LB, Devesa SS. Lung cancer. Cancer. 1995; 75(12):191-202. PubMed | Google Scholar

  6. Youlden DR, Cramb SM, Baade PD, Peter D. The international epidemiology of lung cancer: geographical distribution and secular trends. J Thorac Oncol. 2008;3(8):819-831. PubMed | Google Scholar

  7. Devesa SS, Bray F, Vizcaino AP, Parkin DM. International lung cancer trends by histologic type: male female differences diminishin and adenocarcinoma rates rising. Int J Cancer. 2005;117(2):294-299. PubMed | Google Scholar

  8. Thun MJ, Lally CA, Flannery JT, Calle EE, Flanders WD, Heath CW JR. Cigarette smoking and changes in the histopathology of lung cancer. J Nat Cancer Int. 1997; 89(21):1580-6. PubMed | Google Scholar

  9. Lam B, Lam WK, Lam CL, Ooi GC, Ho JC, Wong MP et al. Adenocarcinoma of the lung in Chinese patients: a revisit and some perspectives from the literature. Postgrad Med J. 2001;77(913):708-12. PubMed | Google Scholar

  10. Capewell S, Wathen CG, Sankaran R, Sudlow MF. Lung cancer in young patients. Respir Med. 1992;86(6):499-502. PubMed | Google Scholar

  11. Rouquettea I, Lauwers-Cancesb V, Alleraa C, Bouchetc L, Miliad J, Nicaisea Y et al. Characteristics of lung cancer in women: importance of hormonal and growth factors. Lung Cancer. 2012;76(3):280-285. PubMed | Google Scholar

  12. Siegfried JM, Hershberger PA, Stabile LP. Estrogen receptor signaling in lung cancer. Semin Oncol. 2009; 36(6):524-31. PubMed | Google Scholar

  13. Antoine M. Qu'apporte l'immunohistochimie à la prise en charge du cancer bronchique? Rev Pneumol Clin. 2007; 63(3): 183-92. PubMed | Google Scholar

  14. Bjerager M, Palshof T, Dahl R, Vedsted P, Olesen F. Delay in diagnosis of lung cancer in general practice. Br J Gen Pract. 2006;56(532):863-8. PubMed | Google Scholar

  15. Salomaa ER, Sallinen S, Hiekkanen H, Liippo K. Delays in the diagnosis and treatment of lung cancer. Chest. 2005; 128(4): 2282-88. PubMed | Google Scholar

  16. Ettinger DS, Akerley W, Borghaei H, Chang AC, Cheney RT, Cirieac LR et al. Guidelines in oncology Non small cell lung cancer. J Natl Compr Canc Netw. 2013 Jun 1;11(6):645-53. PubMed | Google Scholar

  17. Charloux A, Hedelin G, Dietemann A, Ifoundza T, Roeslin N, Pauli G et al. Prognostic value of histology in patients with non-small cell lung cancer. Lung Cancer. 1997; 17(1):123-34. PubMed | Google Scholar

  18. Milleron B. La survie des cancers bronchiques non à petites cellules s'est-elle améliorée au cours de ces vingt dernières années? Rev Pneumol Clin. 2005;61(4 Pt 2):4S31-5. PubMed | Google Scholar

  19. Grivaux M, Zureik M, Marsal L, Asselain B, Peureux M, Chavaillon JM et al. Survie à cinq ans des cancers bronchiques primitifs dans les centres hospitaliers généraux. Rev Mal Respir. 2009;26(1):37- 44. PubMed | Google Scholar